SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing sharp selling pressure as a disappointing second-quarter outlook and the surprise departure of co-founder Reed Hastings from the board overshadowed a strong headline earnings beat. While some investors remain bullish on the stock as a long-term profit machine, many in the community are actively debating whether this pullback represents a prime buying opportunity or a signal that the streaming giant's period of explosive growth is finally cooling.

Based is a financial superapp built on Hyperliquid that lets users trade crypto, equities, and commodities from a single interface, fund accounts directly from bank accounts or credit cards, and spend balances at over 100 million merchants worldwide using a Visa Platinum card that converts at the point of sale with no separate off-ramp required. The platform operates across web, iOS, Android, and desktop with one account, and includes features like curated Launchpools for early project access and AI-native wallets for autonomous trading and risk monitoring.

Based Token

BASED is experiencing heightened volatility and intense community debate, with some investors highlighting its potential as a comprehensive crypto super-app, while others express frustration over frequent price swings and concerns regarding speculative trading activity. Discussions center on its integration within the Base ecosystem and varying sentiments about whether the token is currently in a consolidation phase or prone to further manipulation.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

The RETIRE token is gaining traction as community members frame it as a grassroots alternative to traditional 401(k) systems, actively promoting it as a "last play" for financial independence. Investors are heavily focused on community-led growth, with many advocating for recurring dollar-cost averaging to build long-term positions while the project continues to trend as a rallying point for those looking to bypass conventional retirement structures.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is currently a major focus for traders due to intense volatility following a reverse split, which has tightened the float and sparked speculation about a potential short squeeze. Community sentiment is deeply polarized, with bulls tracking federal news developments and tight supply metrics, while skeptics warn of persistent dilution risks and the company's historical tendency for sharp price reversals.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is facing intense downward pressure and fresh record lows amid investor frustration over persistent capital raises, dilution concerns, and ongoing quality control issues like vehicle recalls. While some community members remain bullish on the brand's premium technology and long-term partnerships, the prevailing sentiment is heavily clouded by concerns regarding the company's cash burn and lack of profitability.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies has emerged as a focal point for traders due to its recent public listing and unique photonic approach to quantum computing, which differentiates it from superconducting rivals. The community is actively debating whether the stock is a long-term play backed by strategic partnerships or a speculative vehicle driven by low-float momentum and high retail engagement.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing extreme volatility as a massive short squeeze collides with concerns over the company's high debt and active share dilution programs. The community is sharply divided, with bulls betting on further upside momentum while bears warn of an imminent collapse toward fundamental valuations, highlighting the stock's status as a high-stakes battleground for short sellers and momentum traders.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is currently trending as the community debates its potential for a rally amid broader market volatility and speculation regarding potential ETF filings. Traders are actively discussing accumulation strategies during dips, with many expressing divided sentiment over whether the token is a long-term play or subject to cyclical pump-and-dump mechanics.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is seeing intense volatility as traders oscillate between buying dips on perceived de-escalation news and hedging against broader geopolitical risks related to the U.S.-Iran conflict. The community remains deeply divided, with many actively debating whether to accumulate shares for a longer-term recovery or lean into bearish puts as they navigate unstable energy prices and conflicting headlines.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently experiencing intense community debate, with bulls citing potential utility and long-term ecosystem development while bears express frustration over price stagnation and the project's pivot toward the Janction ecosystem. Investors remain divided, with some actively accumulating at current levels in anticipation of future news cycles, while others criticize the lack of communication from leadership and the token's persistent underperformance relative to broader crypto market trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Repare Therapeutics Inc. (NASDAQ:RPTX) Short Interest Up 125.3% in January

Repare Therapeutics Inc. (NASDAQ:RPTX - Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totaling 437,896 shares, an...

Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that its Shareholders (as defined below) have approved the acquisition of...

Repare Therapeutics Inc. (NASDAQ:RPTX) Short Interest Update

Repare Therapeutics Inc. (NASDAQ:RPTX - Get Free Report) saw a large decrease in short interest during the month of December. As of December 31st, there was short interest totaling 194,336 shares, a...

Repare Therapeutics (NASDAQ:RPTX) Stock Price Up 0.4% - Here's Why

Repare Therapeutics (NASDAQ:RPTX) Shares Up 0.4% - Still a Buy...

Repare Therapeutics Sees Unusually Large Options Volume (NASDAQ:RPTX)

Repare Therapeutics Inc. (NASDAQ:RPTX - Get Free Report) saw some unusual options trading on Wednesday. Stock investors bought 3,187 call options on the company. This represents an increase of 407...

Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million

Gilead agreed to acquire Repare's RP-3467 cancer drug for up to $30 million, boosting Repare's cash and expected shareholder payout.read more...

<ul class="summary-bullets"><li>The deal includes an upfront payment of $25 million and an additional $5 million payment upon completion of specified technology transfer activities.</li><li>Repare’s investigational cancer treatment, RP-3467, is a highly potent small-molecule inhibitor targeting polymerase theta.</li><li>The treatment is currently being evaluated in the POLAR Phase 1 clinical trial to evaluate its safety, pharmacokinetics, pharmacodynamics, and preliminary activity.</li></ul>Repare Therapeutics Inc. (RPTX) shares soared more than 21% in Wednesday’s pre-market trade after the company announced a deal with Gilead Sciences Inc. (GILD) for its investigational cancer treatment.Repare stated that Gilead has agreed to acquire polymerase theta (Polθ) ATPase inhibitor, RP-3467, for a total consideration of $30 million. This includes an upfront payment of $25 million and an additional $5 million payment upon completion of specified technology transfer activities.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/RPTX">Repare Therapeutics</a> trended in the ‘extremely bullish’ territory at the time of writing.<a href="https://stocktwits.com/symbol/GILD">Gilead Sciences shares</a> were up around 1% in Wednesday’s pre-market trade. Retail sentiment around the company trended in the ‘neutral’ territory.<h2 class="st-heading-2">More About Repare’s Cancer Treatment</h2>Repare’s investigational cancer treatment, RP-3467, is a highly potent small-molecule inhibitor targeting polymerase theta. This is associated with BRCA mutations and other genomic alterations.A BRCA mutation is a harmful change in the BRCA1 or the BRCA2 genes that increases the risk for several cancers, including breast, ovarian, prostate, pancreatic, and others. This mutation is inherited and has no symptoms.Repare’s treatment is currently being evaluated in the POLAR Phase 1 clinical trial to evaluate its safety, pharmacokinetics, pharmacodynamics, and preliminary activity.<h2 class="st-heading-2">Boosting Repare’s Cash Balance</h2>Repare stated that the Gilead deal has increased its cash balance, and it is the third portfolio deal entered into by the company this year.Following this deal, Repare estimates that its shareholders will receive $2.2 per share in the pending transaction with XenoTherapeutics Inc. Last month, XenoTherapeutics entered into a definitive agreement to acquire all the issued and outstanding common shares of Repare.Under the deal’s terms, Repare’s shareholders were expected to receive approximately $1.82 in cash per share, along with one non-transferable contingent value right (CVR) per common share. This CVR entitles holders to receive certain future cash payments over 10 years.<a href="https://stocktwits.com/symbol/RPTX">RPTX stock</a> is up 61% year-to-date, while&nbsp;<a href="https://stocktwits.com/symbol/GILD">GILD stock</a> is up 34%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/is-stock-market-open-on-christmas-eve/cLesMeFREv2">Is The Stock Market Open Today? Here Are NYSE, Nasdaq Trading Hours On Christmas Eve</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

RPTX Stock Soars Pre-Market After Gilead Agrees To Acquire Investigational Cancer Drug

Repare stated that Gilead has agreed to acquire polymerase theta (Polθ) ATPase inhibitor, RP-3467, for a total consideration of $30 million.

Equity

Repare Therapeutics Announces Acquisition of Pol ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive asset purchase agreement for Gilead Sciences, Inc. to...

Halper Sadeh LLC Encourages UBFO, CWBC, RPTX Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages UBFO, CWBC, RPTX Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages UBFO, CWBC, RPTX Shareholders to Contact the Firm to Discuss Their...

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RPTX, FRGE, CSGS, FIZN

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RPTX, FRGE, CSGS, FIZN $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RPTX, FRGE...

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.31	--	--	N/A
Q4 '25	-$0.29	--	--	N/A
Q3 '25	-$0.23	$0.08	134.31%	BEAT
Q2 '25	-$0.56	-$0.39	30.28%	BEAT
Q1 '25	-$0.65	-$0.71	-8.40%	MISSED

RPTX
Repare Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest RPTX News

RPTXRepare Therapeutics Inc